- Home
- NEO vs JPC Comparison
NEO vs JPC Comparison
Compare NEO & JPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEO
- JPC
- Stock Information
- Founded
- NEO 2001
- JPC 2003
- Country
- NEO United States
- JPC United States
- Employees
- NEO N/A
- JPC N/A
- Industry
- NEO Precision Instruments
- JPC Investment Managers
- Sector
- NEO Health Care
- JPC Finance
- Exchange
- NEO Nasdaq
- JPC Nasdaq
- Market Cap
- NEO 2.3B
- JPC 2.6B
- IPO Year
- NEO 1999
- JPC N/A
- Fundamental
- Price
- NEO $16.53
- JPC $7.93
- Analyst Decision
- NEO Strong Buy
- JPC
- Analyst Count
- NEO 10
- JPC 0
- Target Price
- NEO $20.30
- JPC N/A
- AVG Volume (30 Days)
- NEO 756.1K
- JPC 998.5K
- Earning Date
- NEO 02-18-2025
- JPC 01-01-0001
- Dividend Yield
- NEO N/A
- JPC 7.57%
- EPS Growth
- NEO N/A
- JPC N/A
- EPS
- NEO N/A
- JPC N/A
- Revenue
- NEO $644,118,000.00
- JPC N/A
- Revenue This Year
- NEO $12.98
- JPC N/A
- Revenue Next Year
- NEO $9.83
- JPC N/A
- P/E Ratio
- NEO N/A
- JPC N/A
- Revenue Growth
- NEO 12.06
- JPC N/A
- 52 Week Low
- NEO $12.77
- JPC $5.94
- 52 Week High
- NEO $21.22
- JPC $7.36
- Technical
- Relative Strength Index (RSI)
- NEO 44.50
- JPC 39.93
- Support Level
- NEO $17.24
- JPC $7.79
- Resistance Level
- NEO $18.20
- JPC $8.11
- Average True Range (ATR)
- NEO 0.70
- JPC 0.07
- MACD
- NEO -0.28
- JPC -0.03
- Stochastic Oscillator
- NEO 6.41
- JPC 35.53
About NEO NeoGenomics Inc.
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.
About JPC Nuveen Preferred & Income Opportunities Fund
Nuveen Preferred & Income Opportunities Fund is a diversified closed-end management investment company. Its investment objective is to provide high current income and total return. It invests its managed assets in preferred securities, and in other types of securities, primarily income-oriented securities such as corporate and taxable municipal debt and common equity.